You have probably seen L-arginine and L-citrulline on the label of every pre-workout on the shelf. The marketing promise is simple: more blood flow, more oxygen, better performance. But when you actually look at what 22 peer-reviewed studies say, the picture is more nuanced — and more useful — than the labels suggest.

The Performance Question Every Athlete Asks

Whether you are chasing a new squat PR, pushing through the final intervals of a cycling session, or trying to recover faster between training days, the underlying physiology is the same: your muscles need oxygen and nutrients, delivered through blood vessels that can open wide enough to meet demand. Nitric oxide (NO) is the molecule that tells those blood vessels to relax and widen. More NO, in theory, means more blood flow to working muscle.

That is the premise behind the entire NO-booster supplement category. L-arginine is the direct raw material your body uses to make NO via the enzyme eNOS. L-citrulline gets converted to arginine in your kidneys, effectively topping up arginine from a route that avoids the liver’s heavy first-pass metabolism. Combined, the two amino acids are meant to saturate the NO production pathway from both angles.

The real question is whether that mechanistic logic translates to measurable improvement in the gym, on the track, or during recovery. That is what the clinical evidence actually tells us.

L-Arginine and L-Citrulline: Your Body’s NO Precursor System

L-arginine is a semi-essential amino acid and the sole substrate for nitric oxide synthesis. When you take 10 g orally, however, only about 20% reaches your bloodstream — the rest is broken down by arginase enzymes in your gut and liver before it ever gets to your muscles (Tangphao et al., 1999). That hepatic first-pass problem is exactly why L-citrulline was added to the equation.

L-citrulline slips past the liver entirely and is converted to arginine in the kidneys. Schwedhelm et al. (2008) showed that citrulline raises plasma arginine levels more effectively than the same dose of arginine itself. A preclinical study by Morita et al. (2014) found that combining both amino acids produced faster and greater increases in NO bioavailability than either one alone — though this has not yet been confirmed in human performance trials.

How Arginine + Citrulline Works: Four Pathways

What 22 Studies Actually Found

The evidence base spans 8 systematic reviews and meta-analyses, 9 RCTs, 1 dedicated safety trial, and 4 pharmacokinetic studies — covering muscular endurance, maximal strength, aerobic capacity, sprint power, and recovery. The results are genuinely mixed, and honest reporting of that is more useful than cherry-picking the positive findings.

Why This Matters for Your Training

The honest takeaway is that arginine and citrulline are not going to transform your performance. What they may do is help at the margins — a few extra reps before failure, slightly lower perceived effort during tough sets, and less soreness the next day. For someone training consistently at a high volume, those margins compound over weeks and months of training.

The evidence is clearer about who benefits most. Studies consistently show that well-trained athletes see minimal effects — their vascular system is already optimised. The biggest responses appear in recreational athletes, older adults, and people returning to training after a break, where there is more room for improvement in blood vessel function and NO responsiveness.

Timing also matters. Most positive studies administered citrulline 60 minutes before exercise on an empty stomach. The pharmacokinetic data supports fasted administration — without competing dietary amino acids, absorption and conversion to arginine are more efficient. Whether chronic twice-daily dosing adds benefit beyond acute pre-workout use remains an open question.

The Evidence-Based Protocol

What the Research Doesn’t Yet Tell Us

No human study has tested the exact protocol of 10 g L-arginine + 3 g L-citrulline taken fasted twice daily. Most citrulline research uses citrulline malate at 6–8 g — a different compound that delivers more citrulline per dose. The only two combined supplementation trials (Suzuki 2019; Selvaraj 2025) used different doses and produced contradictory results, making it impossible to draw firm conclusions about the specific combination.

The “arginine paradox” remains unresolved: intracellular arginine concentrations already far exceed what eNOS needs, yet exogenous arginine sometimes still affects NO production. Until this is better understood, the translation from “higher plasma arginine” to “better performance” remains inconsistent — particularly for athletes whose vascular system is already functioning well. Research on fasted versus fed administration and long-term chronic dosing is essentially absent.